|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash Flows from Operating Activities: | |||||
| Net loss | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation of property and equipment | |||||
| Impairment charges, net | |||||
| Amortization of internal use software and other intangible assets | |||||
| Gain on sale of loans, net | |||||
| Non-cash interest and amortization of debt issuance costs and discounts | |||||
| Other non-cash adjustments | |||||
| Change in fair value of warrants and equity related liabilities | |||||
| Change in fair value of convertible preferred stock warrants | |||||
| Change in fair value of bifurcated derivative | |||||
| Stock-based compensation | |||||
| Recovery of loan repurchase reserve | |||||
| Provision for credit losses | |||||
| Amortization/accretion of deferred fees and costs | |||||
| Change in fair value of derivatives | |||||
| Change in fair value of loans held for investment attributable to hedged risk | |||||
| Change in fair value of mortgage loans held for sale | |||||
| Change in right-of-use assets | |||||
| Loss on disposal of assets held for sale | |||||
| Change in operating lease of right-of-use assets | |||||
| Originations of mortgage loans held for sale | |||||
| Proceeds from sale of mortgage loans held for sale | |||||
| Change in operating assets and liabilities: | |||||
| Other receivables, net | |||||
| Prepaid expenses and other assets | |||||
| Operating lease liabilities | |||||
| Accounts payable and accrued expenses | |||||
| Escrow payable | |||||
| Escrow payable and other customer accounts | |||||
| Other liabilities | |||||
| Net cash used in operating activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchase of property and equipment | |||||
| Payment to dispose of assets held for sale | |||||
| Proceeds from sale of property and equipment | |||||
| Capitalization of internal use software | |||||
| Acquisitions of businesses, net of cash acquired | |||||
| Maturities of short-term investments | |||||
| Purchase of short-term investments | |||||
| Origination of loans held for investment | |||||
| Principal payments received on loans held for investment | |||||
| Net cash used in investing activities | |||||
| Cash Flows from Financing Activities: | |||||
| Issuance of convertible notes | |||||
| Principal payments on convertible notes | |||||
| Exercise of convertible preferred stock warrants | |||||
| Proceeds from Business Combination | |||||
| Principal payments on senior notes | |||||
| Net borrowings on warehouse lines of credit | |||||
| Repayments on finance lease liabilities | |||||
| Net increase in customer deposits | |||||
| Repayments on corporate line of credit | |||||
| Payment of debt issuance costs | |||||
| Transaction costs related to the Business Combination | |||||
| Proceeds from issuance of common stock under at-the-market offering | |||||
| Borrowings on warehouse lines of credit | |||||
| Repayments of warehouse lines of credit | |||||
| Proceeds from issuance of common stock and exercise of stock options | |||||
| Repurchase or cancellation of common stock | |||||
| Net cash provided by financing activities | |||||
| Effects of currency translation on cash, cash equivalents, and restricted cash | |||||
| Net decrease in cash, cash equivalents, and restricted cash, including cash classified within assets held for sale | |||||
| Less: net change in cash, cash equivalents and restricted cash classified within assets held for sale | |||||
| Cash, cash equivalents, and restricted cash—Beginning of year | |||||
| Cash, cash equivalents, and restricted cash—End of year | |||||
| Supplemental Disclosure of Cash Flow Information: | |||||
| Interest paid | |||||
| Income taxes paid/(refunded) | |||||
| Non-Cash Investing and Financing Activities: | |||||
| Assumption private placement and public warrants | |||||
| Convertible notes exchange | |||||
| Reduction of lease liability via modification/termination | |||||
| Recognition of derivative liability related to earnout | |||||
| Capitalization of stock-based compensation related to internal use software | |||||
| Vesting of stock options early exercised in prior periods | |||||
| Vesting of common stock issued via notes receivable from stockholders | |||||
| Acquisition earnout | |||||
| Forgiveness of notes receivable from stockholders | |||||
| Settlement of notes receivable from stockholders | |||||
| Reclasses to internal use software | |||||
| Termination of notes receivable from stockholders | |||||
| Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation | |||||
| Cash and cash equivalents, end of year | |||||
| Restricted cash, end of year | |||||
Loading...